Trump accepts finishing his term without a Senate-confirmed FDA commissioner

RUKUS· · 6h ← 4d
Go Rogue

President Trump withdrew Dr. Heidi Overton's nomination to lead the FDA in November 2026, one day before the Senate Health Committee was to vote on her confirmation.

Overton, a White House domestic policy aide nominated in August, faced opposition over her stances on vaccines, vaping and abortion policy.

Senator Bill Cassidy, the committee's Republican chair, said she had the votes and that the administration withdrew her rather than give anti-abortion senators commitments on mifepristone.

The FDA has lacked a permanent commissioner since May, and no replacement is expected to win confirmation before Democrats take Senate control in January 2027.

Her allies suspect Health Secretary Robert F. Kennedy Jr. and chief of staff Stephen Miller soured on her; the White House cited insufficient support in Congress.

  1. The Trump administration withdrew Heidi Overton's nomination to lead the Food and Drug Administration amid signs she lacked the support to be confirmed by the Senate.

    Republican lawmakers on the Senate panel weighing her nomination had raised concerns about Overton's views on vaccine recommendations, vape restrictions and abortion policy.

  2. President Trump nominated Overton, a White House domestic policy aide, as FDA commissioner in August 2026, and Health Secretary Robert F. Kennedy Jr. praised the choice.

    Senator Bill Cassidy said on CBS' "Face the Nation" before the withdrawal that "I still have questions, and so I cannot tell you the outcome of that vote right now."

    Calley Means, a Make America Healthy Again advocate, told "The Joe Rogan Experience" that Overton worked to "relax standards on fruit flavored vapes" and accused her of putting corporate interests ahead of the movement's health agenda.

    Vani Hari, the healthy food advocate known as Food Babe, wrote on X, "Another one bites the dust."

    Health in Office spokesperson Jenny Kay said the activists behind the poster campaign have "a lot of concerns around who has already been put in charge of the health of people in this country."

  3. Senator Lisa Murkowski questioned Overton at her hearing about political pressure surrounding access to mifepristone and criticized her for not taking a clear position.

    Senator Susan Collins said she was undecided on Overton's nomination and needed "to get some answers on various things."

    Senator Bill Cassidy wrote on X before Overton's September hearing that he had "strong concerns" about her nomination, saying her lack of managerial experience left her poorly prepared to lead the agency.

  4. At her September 2026 confirmation hearing, Senator Bill Cassidy pressed Overton on whether she would stand up to President Trump on vaccines, particularly the measles vaccine.

    Democrats were alarmed by Overton's past statements calling the abortion pill mifepristone "dangerous to women".

    Senator Bill Cassidy said Overton's role in a summer executive order calling for reducing the number of vaccines recommended for children was "almost disqualifying".

  5. With Democrats expected to oppose her, Overton needed unanimous Republican support in the 21-member Senate Health, Education, Labor and Pensions Committee to advance.

  6. The White House was weighing Senator Roger Marshall of Kansas, a former obstetrician who lost his 2025 re-election bid, as a replacement nominee.

    The nonpartisan group Health in Office launched a campaign branding Overton "Heidi Vaperton," with posters and yard signs across Washington urging senators to say no.

  7. Mini Timmaraju celebrated the White House's decision to pull the nomination.

  8. Senator Bill Cassidy said Overton "probably had the votes" to clear his committee and the Senate, and that conservatives' abortion-related concerns had been substantially satisfied.

    Cassidy said the White House released the withdrawal decision to the press before telling the Senate Health Committee.

    Senator Bill Cassidy called the Trump administration "an unserious regime" and said he was "befuddled" by its decision to pull the nominee.

    Senator Bill Cassidy said prospects for a replacement FDA nominee were dim before Republicans lose their Senate majority in January 2027.

  9. A senior administration official said the nomination was dropped because Overton "lacks the support on the Hill to move forward with her confirmation."

    Senator Bill Cassidy wrote that the White House "abandoned a viable confirmation path" for Overton, withdrawing her "rather than make such commitments" after pro-life senators sought final assurances on life issues.

    Senator Bill Cassidy said that, with the limited time left, confirming a permanent FDA commissioner will fall to Senate Democrats.

  10. Officials had made commitments to Hawley tied to the FDA's ongoing mifepristone safety study, including posting the study's anticipated completion date on the agency's website.

    Overton's allies came to believe the White House used doubts about her Senate support as cover to drop a candidate that Robert F. Kennedy Jr. and Stephen Miller had soured on.

    Health officials dispatched Dr. Mehmet Oz of the Medicare and Medicaid agency to make calls to Republican senators Lisa Murkowski and Susan Collins on Overton's behalf.

    Overton met privately with Senator Bill Cassidy in the week before the withdrawal, in a meeting her team believed had locked in his support.

    Trump officials had no plan to quickly nominate a replacement, raising the prospect of no confirmed FDA commissioner before Democrats take Senate control in January 2027.

    Senator Josh Hawley told reporters Overton's responses were "completely responsive to everything I asked for", praising her for the "strongest commitments any nominee has made on life".

  11. Overton's team learned of the withdrawal from an Axios report hours after making mifepristone concessions to Senator Josh Hawley that officials believed had secured his vote.

  12. Trump acknowledged there appeared to be no path to confirming Heidi Overton when he withdrew her nomination, apparently accepting he would finish his term without a Senate-confirmed FDA commissioner.

Sign in with subscription

Free during the beta.

Clear all notifications?

Your bells stay on. Only this list empties.